Creative Planning’s IGC Pharma IGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-90,449
Closed -$57K 1975
2019
Q4
$57K Buy
90,449
+25,000
+38% +$20.5K ﹤0.01% 1811
2019
Q3
$64K Buy
65,449
+1,410
+2% +$1.7K ﹤0.01% 1768
2019
Q2
$105K Hold
64,039
﹤0.01% 1742
2019
Q1
$133K Buy
+64,039
New +$146K ﹤0.01% 1658
2018
Q4
Sell
-65,049
Closed -$420K 2016
2018
Q3
$420K Hold
65,049
﹤0.01% 1189
2018
Q2
$32K Hold
65,049
﹤0.01% 1877
2018
Q1
$36K Hold
65,049
﹤0.01% 1847
2017
Q4
$65K Hold
65,049
﹤0.01% 1779
2017
Q3
$21K Hold
65,049
﹤0.01% 1832
2017
Q2
$21K Hold
65,049
﹤0.01% 3155
2017
Q1
$21K Hold
65,049
﹤0.01% 3100
2016
Q4
$18K Buy
65,049
+61,899
+1,965% +$21.5K ﹤0.01% 3141
2016
Q3
$1K Hold
3,150
﹤0.01% 4388
2016
Q2
$2K Buy
3,150
+1,100
+54% +$481 ﹤0.01% 4020
2016
Q1
$1K Buy
+2,050
New +$621 ﹤0.01% 4128
2014
Q4
Sell
-28,400
Closed -$20K 4244
2014
Q3
$20K Buy
28,400
+8,250
+41% +$8.03K ﹤0.01% 2540
2014
Q2
$29K Buy
20,150
+5,970
+42% +$6.75K ﹤0.01% 2252
2014
Q1
$11K Buy
14,180
+5,145
+57% +$4.48K ﹤0.01% 2708
2013
Q4
$9K Hold
9,035
﹤0.01% 2612
2013
Q3
$9K Hold
9,035
﹤0.01% 2503
2013
Q2
$14K Buy
+9,035
New +$18.9K ﹤0.01% 2116

Other funds holding IGC

Creative Planning's IGC Position: Q1 2020 in Review

Creative Planning sold out of IGC Pharma (IGC) in Q1 2020, closing a stake of 90,449 shares — an estimated $57K sold.

Creative Planning first reported a position in IGC in Q2 2013 and held it in 21 quarters. The position peaked at $420K in Q3 2018. 21 funds tracked by Wall St. Rank hold IGC as of Q1 2020.

  • Creative Planning reported no remaining IGC Pharma position as of Q1 2020 after selling out during the quarter.
  • Creative Planning sold 90,449 IGC Pharma shares in Q1 2020, an estimated $57K.
  • Creative Planning first reported a position in IGC Pharma in Q2 2013 and held it in 21 quarters.
  • Creative Planning's IGC Pharma position peaked at $420K in Q3 2018.
  • 21 funds tracked by Wall St. Rank held IGC Pharma as of Q1 2020.

Based on Creative Planning's 13F filing for Q1 2020, filed 5 May 2020.